SEARCH

SEARCH BY CITATION

References

  • Apperley, J.F. , Mauro, F.R., Goldman, J.M., Gregory, W., Arthur, C.K., Hows, J., Arcese, W., Papa, G., Mandelli, F., Wardle, D., Gravett, P., Franklin, I.M., Bandini, G., Ricci, P., Tura, S., Iacone, A., Torlontano, G., Hiet, W., Champlin, R.E., Gale, R.P. (1988) Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of a graft-versus-leukaemia effect. British Journal of Haematology, 69, 239245.
  • Atkinson, K., Horowitz, M.M., Gale, R.P., Van-Bekkum, D.W., Gluckman, E., Good, R.A., Jacobsen, N., Kolb, H.J., Rimm, A.A., Ringden, O., Rozman, C., Sobocinski, K., Zwaan, F.E., Bortin, M.M. (1990) Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood, 75, 24592464.
  • Bortin, M.M., Truitt, R.L., Rimm, A.A., Bach, F.H. (1979) Graft-versus-leukaemia reactivity induced by alloimmunisation without augmentation of graft-versus-host reactivity. Nature, 281, 490491.
  • Butturini, A. & Gale, R.P. (1987) The role of T-cells in preventing relapse in chronic myelogenous leukemia. Bone Marrow Transplantation, 2, 351354.
  • Butturini, A., Bortin, M.M., Gale, R.P. (1987) Graft-versus-leukemia following bone marrow transplantation. Bone Marrow Transplantation, 2, 233242.
  • Gale, R.P. & Champlin, R.E. (1984) How does bone-marrow transplantation cure leukaemia? Lancet, 2, 2830.
  • Gale, R.P. & Reisner, Y. (1986) Graft rejection and graft-versus-host disease: mirror images. Lancet, 1, 14681470.
  • Horowitz, M.M., Gale, R.P., Sondel, P.M., Goldman, J.M., Kersey, J., Kolb, H.J., Rimm, A.A., Ringden, O., Rozman, C., Speck, B., Truitt, R.L., Zwaan, F.E., Bortin, M.M. (1990) Graft-versus-leukemia reactions after bone marrow transplantation. Blood, 75, 555562.
  • Kaplan, E.L. & Meier, P. (1958) Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457.
  • Maraninchi, D., Gluckman, E., Blaise, D., Guyotat, D., Rio, B., Pico, J.L., Leblond, V., Michallet, M., Dreyfus, F., Ifrah, N., Bordigoni, A. (1987) Impact of T-cell depletion on outcome of allogeneic bone-marrow transplantation for standard-risk leukaemias. Lancet, 2, 175178.
  • Marmont, A.M., Horowitz, M.M., Gale, R.P., Sobocinski, K., Ash, R.C., Van-Bekkum, D.W., Champlin, R.E., Dicke, K.A., Goldman, J.M., Good, R.A., Herzig, R.H., Hong, R., Masoaka, T., Rimm, A.A., Ringden, O., Speck, B., Weiner, R.S., Bortin, M.M. (1991) T-cell depletion of HLA-identical transplants in leukemia. Blood, 78, 21202130.
  • Moscovitch, M. & Slavin, S. (1984) Anti-tumor effects of allogeneic bone marrow transplantation in (NZB X NZW) F1 hybrids with spontaneous lymphosarcoma. Journal of Immunology, 132, 9971000.
  • Papadopoulos, E.B., Carabasi, M.H., Castro, M.H., Childs, B.H., Mackinnon, S., Boulad, F., Gillio, A.P., Kernan, N.A., Small, T.N., Szabolcs, P., Taylor, J., Yahalom, J., Collins, N.H., Bleau, S.A., Black, P.M., Heller, G., O'Reilly, R.J., Young, J.W. (1998) T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease. Blood, 91, 10831090.
  • Sullivan, K.M., Witherspoon, R.P., Storb, R., Deeg, H.J., Dahlberg, S., Sanders, J.E., Appelbaum, F.R., Doney, K.C., Weiden, P.L., Anasetti, C., Loughran, T.P., Hill, R., Shields, A., Yee, G., Shulman, H.M., Nims, J., Strom, S., Thomas, E.D. (1988) Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft versus host disease. Blood, 72, 555.
  • Sullivan, K.M., Storb, R., Buckner, C.D., Fefer, A., Fisher, L., Weiden, P.L., Witherspoon, R.P., Appelbaum, F.R., Banaji, M., Hansen, J., Martin, P., Sanders, J.E., Singer, J., Thomas, E.D. (1989) Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms. New England Journal of Medicine, 320, 828834.
  • Thomas, E.D., Storb, R., Clift, R.A., Fefer, M., Johnson, F.L., Neiman, P.F., Lerner, K.G., Glucksberg, H., Buckner, C.D. (1975) Bone marrow transplantation. New England Journal of Medicine, 292, 832843.
  • Tutschka, P.J., Berkowitz, S.D., Tuttle, S., Klein, J. (1987) Graft-versus-leukemia in the rat – the antileukemic efficacy of syngeneic and allogeneic graft-versus-host disease. Transplant Proceedings, 19, 26682673.
  • Verdonck, L.F., De Gast, G.C., Van Heugten, H.G., Dekker, A.W. (1990) A fixed low number of T cells in HLA-identical allogenic bone marrow transplantation. Blood, 75, 776780.
  • Verdonck, L.F., Dekker, A.W., Rozenberg-Arska, M., Van den Hoek, M.R. (1997) A risk-adapted approach with a short course of ganciclovir to prevent cytomegalovirus (CMV) pneumonia in CMV-seropositive recipients of allogeneic bone marrow transplants. Clinical Infectious Diseases, 24, 901907.
  • Weiden, P.L., Flournoy, N., Thomas, E.D., Prentice, R., Fefer, A., Buckner, C.D., Storb, R. (1979) Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. New England Journal of Medicine, 300, 10681073.
  • Weiden, P.L., Sullivan, K.M., Flournoy, N., Storb, R., Thomas, E.D. and the Seattle marrow transplant team (1981) Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. New England Journal of Medicine, 304, 15291533.